4//SEC Filing
Johnson John Paul 4
Accession 0001628908-24-000034
CIK 0001628908other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:09 PM ET
Size
8.2 KB
Accession
0001628908-24-000034
Insider Transaction Report
Form 4
Johnson John Paul
Chief Financial Officer
Transactions
- Award
Class A Common Stock
2024-03-01+12,123→ 236,133 total - Tax Payment
Class A Common Stock
2024-03-01$34.41/sh−11,213$385,839→ 224,920 total - Tax Payment
Class A Common Stock
2024-03-02$34.41/sh−9,020$310,378→ 215,900 total
Footnotes (4)
- [F1]Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- [F2]Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027.
- [F3]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F4]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001782040
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 7:09 PM ET
- Size
- 8.2 KB